1811 related articles for article (PubMed ID: 33692570)
1. COVID-19 and liver disease: mechanistic and clinical perspectives.
Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
[TBL] [Abstract][Full Text] [Related]
3. Management of COVID-19 patients with chronic liver diseases and liver transplants.
Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
[TBL] [Abstract][Full Text] [Related]
4. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P
Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 and the liver.
Esteban JP; Sobotka L; Rockey DC
Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
[TBL] [Abstract][Full Text] [Related]
6. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
7. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.
Vitale G; Gitto S; Marra F; Morelli MC
Intern Emerg Med; 2022 Jan; 17(1):15-24. PubMed ID: 34245423
[TBL] [Abstract][Full Text] [Related]
8. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
12. Review article: COVID-19 and liver disease-what we know on 1st May 2020.
Garrido I; Liberal R; Macedo G
Aliment Pharmacol Ther; 2020 Jul; 52(2):267-275. PubMed ID: 32402090
[TBL] [Abstract][Full Text] [Related]
13. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and the liver: A 2021 update.
Spearman CW; Aghemo A; Valenti L; Sonderup MW
Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and comorbidities of hepatic diseases in a global perspective.
Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
[TBL] [Abstract][Full Text] [Related]
16. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases.
Baiges A; Cerda E; Amicone C; Téllez L; Alvarado-Tapias E; Puente A; Fortea JI; Llop E; Rocha F; Orts L; Ros-Fargas O; Vizcarra P; Zekrini K; Lounes OA; Touati G; Jiménez-Esquivel N; Serrano MJ; Falgà A; Magaz M; Olivas P; Betancourt F; Perez-Campuzano V; Turon F; Payancé A; Goria O; Rautou PE; Hernández-Gea V; Villanueva C; Albillos A; Plessier A; García-Pagán JC
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1525-1533.e5. PubMed ID: 34968728
[TBL] [Abstract][Full Text] [Related]
17. Liver dysfunction and SARS-CoV-2 infection.
Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
[TBL] [Abstract][Full Text] [Related]
18. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
[TBL] [Abstract][Full Text] [Related]
19. [Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review].
Maev IV; Osadchuk MA
Ter Arkh; 2022 Dec; 94(11):1326-1332. PubMed ID: 37167173
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
Cha MH; Regueiro M; Sandhu DS
World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
